Bruce Huang

发表

WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.

K. Tsang, Duane H. Hamilton, C. Palena, 2014, Cancer research.

Therapeutics , Targets , and Chemical Biology WEE 1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial – Mesenchymal Transition

K. Tsang, Duane H. Hamilton, C. Palena, 2014 .

RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency.

T. Wu, Chih-Ping Mao, C. Hung, 2008, Human gene therapy.

Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency.

T. Wu, Chih-Ping Mao, C. Hung, 2007, Vaccine.

MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma

D. Lu, Kuo-Chen Wei, P-Y Chen, 2017, Oncogene.

An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype

C. Larocca, Duane H. Hamilton, C. Palena, 2013, Molecular Cancer Therapeutics.

Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

F. Guadagni, J. Schlom, H. Lyerly, 2014, Journal of the National Cancer Institute.

Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine

J. Schlom, Andressa Ardiani, J. Hodge, 2013, Oncotarget.

Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.

Duane H. Hamilton, C. Palena, R. Fernando, 2012, Seminars in oncology.

Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

F. Guadagni, J. Schlom, A. Spila, 2012, Clinical Cancer Research.

Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells

J. Schlom, Duane H. Hamilton, C. Palena, 2011, Experimental biology and medicine.

Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax

D. Rotstein, H. Fang, D. M. Frucht, 2015, Toxins.

Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination

T. Wu, C. Hung, A. Monie, 2008, Journal of Molecular Medicine.

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

B. Huang, J W Hodge, J. Hodge, 2013, Cell Death and Disease.

WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.

K. Tsang, Duane H. Hamilton, C. Palena, 2014, Cancer research.

Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

F. Guadagni, J. Schlom, A. Spila, 2012, Clinical Cancer Research.